You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


University of Edinburgh spinout Cellinta will develop gene therapies for cancer

A biotech company spun out of the University of Edinburgh will utilise research to develop new gene therapies to target different types of cancer.